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Abstract
Objective: High serum uric acid (UA) levels are associated with the metabolic syndrome, type 2 diabetes and cardiovascular
disease. It is largely unknown whether there are gender-specific differences regarding the association between UA and
prediabetic states. We examined the possible association between UA levels and known as well as newly diagnosed
diabetes (NDD), isolated impaired fasting glucose (i-IFG), isolated impaired glucose tolerance (i-IGT), and combined IFG/IGT
in a population-based sample of 32-to-81-year-old men and women.
Research Design and Methods: An oral glucose tolerance test was carried out in all 2,740 participants without known
diabetes of the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study conducted between 2006 and
2008 in Southern Germany. Serum UA was analysed by the uricase method.
Results: In women after multivariable adjustment the associations between UA and i-IFG (OR 1.57, 95% CI 1.15–2.14), IFG/
IGT (OR 1.52, 1.07–2.16), NDD (OR 1.67, 95% CI 1.28–2.17), and known diabetes (OR 1.47, 95% CI 1.18–1.82) remained
significant, but the association with i-IGT (OR 1.14, 95% CI 0.95–1.36) lost significance. In contrast in men, after multivariable
adjustment there was only a significant association between UA levels and i-IFG (OR 1.49, 95% CI 1.21–1.84), all other
associations were non-significant (i-IGT: OR 1.09, IFG/IGT: OR 1.06, NDD: OR 0.91, known diabetes: OR 1.04; all p-
values.0.05).
Conclusions: Serum UA concentrations were associated with different categories of impaired glucose regulation in
individuals from the general population, particularly in women. Further studies investigating the role of UA in the
development of derangements in glucose metabolism are needed.
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Introduction
Uric acid is the final oxidation product of purine metabolism in
humans. There is evidence that hyperuricemia is associated with
the metabolic syndrome [1,2] and incident type 2 diabetes [3,4].
While some investigations found no association between uric acid
levels and the risk of diabetes mellitus [5], in a recent meta-analysis
a positive association was reported [6]. Although uric acid levels
are substantially different between men and women [7], most of
the prior studies on this issue were conducted in male populations
alone and, if including both men and women, did not conduct
gender specific analyses [8–10]. Thus, it remains largely unknown
whether there are gender differences regarding the relationship
between uric acid levels and impaired glucose regulation.
In addition, so far, population-based data to determine whether
uric acid levels are associated with different stages of impaired
glucose regulation, in particular prediabetic states, is scarce [11–
13]. Therefore, the present study was set out to investigate the
possible association between uric acid levels and known diabetes,
newly diagnosed diabetes (NDD), isolated impaired fasting glucose
(i-IFG), isolated impaired glucose tolerance (i-IGT), and combined
IFG/IGT in a population of 32-to-81-year-old men and women in
Southern Germany. Given the marked differences in serum uric
acid levels between men and women, gender-specific analysis was
performed.
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Methods
Data are based on the Cooperative Health Research in the
Region of Augsburg (KORA) F4 study (2006–2008), a follow-up of
the KORA S4 study, a population-based health survey conducted
in the city of Augsburg and two surrounding counties between
1999 and 2001. For S4 a total sample of 6,640 subjects was drawn
from the target population consisting of all German residents of
the region aged 25 to 74 years. Of all 4,261 participants of the S4
baseline study, 3,080 also participated in the 7-year follow-up F4
study. Persons were considered ineligible for F4 if they lived
outside the study region or were completely lost to follow-up
(n = 206, 5%), or had demanded deletion of their address data
(n = 12, 0.2%). Furthermore, 176 persons (4%) had died during
follow-up time. Of the remaining 3,867 eligible persons, 174 could
not be contacted, 218 were unable to come because they were too
ill or had no time, and 395 were not willing to participate in this
follow-up, resulting in a response rate of 79.6%. The current study
was restricted to 2,970 subjects (1539 women and 1431 men)
without missing values of any of the analytical variables (n = 110)
(see Figure 1). The investigations were carried out in accordance
with the Declaration of Helsinki, including written informed
consent of all participants. All study methods were approved by
the Ethics committee of the ‘‘Bayerische Landesa¨rztekammer’’
Munich.
Known diabetes was defined as validated physician diagnosis or
current use of antidiabetic agents. As type 2 diabetes mellitus
constitutes approximately 95% of all cases of diabetes in the
Western countries it can be assumed that most of the persons who
have known diabetes in this study suffer from type 2 diabetes. After
an overnight fast of at least 10 hours, all nondiabetic participants
underwent a standard 75-g oral glucose tolerance test (OGTT)
[14]. In persons with known diabetes no OGTT was carried out.
NDD, i-IGT, i-IFG, and normal glucose tolerance (NGT) were
defined according to the 1999 WHO diagnostic criteria based on
both fasting and 2-h-glucose values [15]. We have used the
original IFG criteria (6.1 to 6.9 mmol/l) for the present analysis, as
recommended by the European Diabetes Epidemiology Group
[16].
Data collection
Information on sociodemographic variables, smoking habits,
physical activity level, and alcohol consumption was gathered by
trained medical staff during a standardized interview. Education
was estimated by recording years of schooling completed. In
addition all participants underwent an extensive standardized
medical examination [17]. A regular smoker was defined as a
subject who smoked at least one cigarette per day at baseline.
Alcohol intake was categorized into two categories: men: ,40 or
$40 g/d; women: ,20 or $20 g/d. Body mass index (BMI) was
calculated as weight in kilograms divided by height in square
meters. Waist circumference was measured at the level midway
between the lower rib margin and the iliac crest. Systolic and
diastolic blood pressure were measured three times at the right
arm of seated subjects, after at least five minutes at rest, and by use
of an oscillometric digital blood pressure monitor (HEM-705CP,
Omron Corporation, Tokyo, Japan). The pause between readings
was three minutes. The mean of the second and third measure-
ment was calculated and used for the present analyses. Hyperten-
sion was defined as blood pressure values $140/90 mm Hg and/
or use of antihypertensive medication given that the subjects were
aware of being hypertensive. Individuals who participated in
leisure time physical training during summer and winter and were
Figure 1. Flow chart describing the selection and subsequent loss of participants.
doi:10.1371/journal.pone.0037180.g001
Uric Acid and Impaired Glucose Regulation
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37180
active for at least one hour per week in either season were classified
as being physically active.
Clinical chemical measurements
A fasting venous blood sample was obtained from all study
participants while sitting. Blood was collected without stasis cooled
at 4–8uC and shipped on refrigerant packaging within 4 to 6 hours
to the laboratory. Blood glucose was analyzed using a hexokinase
method (GLU Flex, Dade Behring). Total serum cholesterol, and
HDL cholesterol analyses were carried out using the CHOD-PAP
method (CHOL Flex, and AHDL Flex). Triglycerides were
measured with the GPO-PAP-method (TGL Flex, Dade Behring).
Serum creatinine was measured using a modified kinetic Jaffe´
reaction. Serum concentrations of uric acid were measured on
fresh samples by the uricase method (enzymatic color-test, URCA
Flex, Dade Behring).
Statistical analyses
Logistic regression models were used to test differences in
prevalences and a general linear model (F-Test) was used to
compare means (reference group NGT). The variables triglycer-
ides and creatinine were markedly skewed and were therefore log-
transformed in analyses where a normal distribution was required.
We performed multinomial logistic regression analyses using the
SAS procedure PROC LOGISTIC to study the association of uric
acid with different categories of impaired glucose regulation. In
these analyses the categorical dependent outcome had six groups
(NGT, i-IFG, i-iGT, IFG/IGT, NDD, and known diabetes) and
the reference group for comparison was NGT. In the analyses four
models were fitted: The first model included uric acid, age
(continuous) and sex. The second model included all previous
factors plus hypertension (yes/no), physical activity (active/
inactive), regular smoker (yes/no), high alcohol intake (yes/no),
and serum creatinine (continuous). The third model included total
cholesterol and HDL cholesterol (both continuous) in addition to
all previous factors and the fourth model included BMI
(continuous) in addition to all previous factors. The above analyses
were repeated by including waist circumference (WC) as a
continuous variable instead of BMI. Furthermore, the association
between hyperuricemia and glucose intolerance categories was
assessed using multinomial regression analysis. The cut-off points
7.0 mg/dl in men and 6.0 mg/dl in women were used in this
analysis.The same stepwise modeling strategy (models 1–4) as
described above was used in the multinomial analysis. Finally, in a
logistic regression analysis the association between uric acid level
(continuous) and all impaired glucose regulation groups combined
as the outcome was investigated. In this analysis, study participants
with i-IFG, i-IGT, IFG/IGT, NDD, and known diabetes were
regarded as persons with impaired glucose regulation and persons
with NGT built the reference group. All analyses were done for
the total sample as well as separately for men and women. A p-
value of ,0.05 was considered statistically significant. All analyses
were performed with SAS software version 9.1. (SAS Institute,
Inc., Cary, NC, USA).
Results
Sex-specific characteristics of the study sample according to
glucose tolerance categories are shown in Table 1 (women) and
Table 2 (men). Women and men with i-iFG, i-IGT, IFG/IGT,
newly diagnosed diabetes, or known diabetes had higher uric acid
levels than reference subjects with NGT. In both sexes glucose
status categories also differed with respect to demographic and
clinical factors. As compared to the NGT group, female and male
subjects with impaired glucose status or newly diagnosed and
known diabetes were older, more likely to be less educated, had a
higher BMI or waist circumference, as well as a higher systolic
blood pressure. Those women and men with impaired glucose
status, newly diagnosed or known diabetes more often suffered
from hypertension. Impaired glucose status and newly, as well as
known diabetes were related to lower HDL cholesterol, higher
triglycerides, higher creatinine values, higher alcohol intake
(women only), non-smoking, and lack of physical activity. As
compared to the NGT group, women and men with impaired
glucose status or newly diagnosed diabetes had higher total
cholesterol values, while persons with known diabetes had lower
total cholesterol values.
The results of the multinomial regression analysis are given in
Table 2. In the total sample uric acid concentration were
significantly associated with glucose status groups after age- and
sex- as well as after multivariable adjustment. In the age- and sex-
adjusted model the OR per mg/dL increment of uric acid was
1.66 (95% CI 1.43–1.92) for i-IFG, 1.26 (95% CI 1.14–1.40) for i-
IGT, 1.57 (95% CI 1.31–1.89) for IFG/IGT, 1.57 (95% CI 1.35–
1.83) for NDD and 1.55 (95% CI 1.38–1.73) for known diabetes.
Further adjustment for smoking status, alcohol intake, physical
activity, actual hypertension, total cholesterol, HDL cholesterol
and creatinine values somewhat attenuated the associations, but
the ORs per mg/dL uric acid increment were still significantly
increased for all glucose status groups compared to persons with
NGT. Additional adjustment for BMI further attenuated the
findings and the associations between uric acid level and the
categories i-IGT and IFG/IGT lost significance, while the
association between uric acid level and i-IFG, NDD, and known
diabetes remained significant (the OR per mg/dL increment of
uric acid was 1.50 for i-IFG, 1.10 for i-IGT, 1.22 for IFG/IGT,
1.18 for NDD, and 1.17 for known diabetes). There were
significant interactions between sex and uric acid levels (see
Table 2). As shown in Table 2 uric acid levels were more strongly
associated with the different glucose tolerance categories in women
compared with men. In women after multivariable adjustment the
associations remained statistically significant for i-IFG, IFG/IGT,
NDD, and known diabetes, but lost significance for i-IGT (model
4: i-IFG: OR 1.57, i-IGT: OR 1.14, IFG/IGT: OR 1.52, NDD:
OR 1.67, known diabetes: OR 1.47). However, in men, in
multivariable analyses there was only a significant association
between uric acid levels and i-IFG, all other associations were non-
significant (model 4: i-IFG: OR 1.49, i-IGT: OR 1.09, IFG/IGT:
OR 1.06, NDD: OR 0.91, known diabetes: OR 1.04).
The strength of the relationship between uric acid levels and
glucose status groups was unchanged after adjusting for waist
circumference instead of BMI in the different models (data not
shown).
When performing the multinomial regression analysis with a
categorized variable hyperuricemia (cut-off value of 6.0 mg/dl for
women and 7.0 mg/dl for men) the results found in the analysis
using the continuous uric acid variable were confirmed. Altogeth-
er, 286 men and 157 women suffered from hyperuricemia.Hyper-
uricemia was more strongly associated with the different glucose
tolerance categories in women compared with men. In women
after multivariable adjustment the associations remained statisti-
cally significant for all single categories of glucose intolerance
(model 4: i-IFG: OR 1.57 (95% CI 1.80–10.41), i-IGT: OR 1.89
(95% CI 1.10–3.24), IFG/IGT: OR 2.88 (95% CI 1.11–7.49),
NDD: OR 3.26 (95% CI 1.53–6.92), known diabetes: OR 2.33
(95% CI 1.26–4.31). In men, in multivariable analyses there was
only a significant association between hyperuricemia and i-IFG, all
other associations were non-significant (model 4: i-IFG: OR 2.48
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Table 1. Study characteristics by NGT, i-IFG, i-IGT, IFG/IGT, NDD, and known diabetes mellitus, men (n = 1431) and women
(n = 1539) aged 32–81 years, KORA F4 study.
NGT i-IFG i-IGT IFG/IGT NDD
Known
diabetes
Men n=971 n=75 n=147 n=42 n=61 n=135
Women n=1,164 n=38 n=168 n=27 n=47 n=95
Age (years)
Men 52.8 (12.8) 60.8 (10.8)** 63.6 (11.2)** 63.1 (10.0)** 65.1 (10.4)** 68.2 (8.9)**
Women 52.8 (12.4) 62.3 (10.8)** 63.8 (11.5)** 66.3 (7.1)** 65.4 (10.6)** 66.3 (9.4)**
Uric acid (mg/dL)
Men 5.8 (1.2) 6.7 (1.4)** 6.3 (1.2)** 6.4 (1.1)** 6.2 (1.5)* 6.3 (1.5)**
Women 4.3 (1.0) 5.2 (1.5)** 4.8 (1.1)** 5.5 (1.0)** 5.7 (1.5)** 5.6 (1.6)**
Education (,12 years, %)
Men 47.0 50.7 53.1 47.6 52.5 67.4**
Women 63.8 65.8 78.6** 77.8 76.6 80.0**
BMI (kg/m2)
Men 27.0 (3.7) 29.7 (3.1)** 29.5 (4.8)** 30.5 (5.1)** 30.8 (4.6)** 29.9 (4.6)**
Women 26.2 (4.8) 30.2 (6.7)** 29.4 (4.8)** 31.3 (4.9)** 31.5 (4.1)** 33.1 (6.0)**
Waist circumference (cm)
Men 96.9 (10.6) 104.9 (10.8)** 104.8 (14.1)** 107.0 (13.4)** 107.9 (11.5)** 107.1 (11.7)**
Women 85.1 (11.9) 97.5 (14.1)** 93.3 (12.1)** 101.6 (12.9)** 100.1 (9.1)** 102.5 (13.6)**
Systolic blood pressure (mm Hg)
Men 125.0 (16.3) 132.1 (18.0)** 131.9 (18.1)** 135.8 (18.2)** 135.1 (18.4)** 134.8 (20.0)**
Women 114.2 (16.8) 128.2 (22.0)** 121.6 (19.0)** 131.7 (13.7)** 127.1 (15.5)** 129.8 (19.2)**
Diastolic blood pressure (mm Hg)
Men 77.3 (9.7) 79.0 (10.0) 78.2 (11.3) 82.4 (10.2)** 79.4 (11.5) 75.6 (10.6)
Women 72.6 (9.3) 74.4 (8.9) 73.1 (9.3) 78.7 (7.3)** 74.0 (9.9) 73.0 (10.2)
Actual hypertension (%)
Men 31.5 56.0** 65.3** 78.6** 75.4** 78.5**
Women 24.2 50.0** 45.8** 55.6** 80.9** 81.1**
Total cholesterol (mg/dL)
Men 213.4 (36.9) 219.2 (44.9) 221.3 (42.6)* 223.3 (37.6) 216.7 (44.7) 194.0 (37.5)**
Women 216.1 (39.2) 231.7 (36.6)* 228.1 (42.3)** 233.5 (37.5)* 222.8 (39.4) 214.2 (40.2)
HDL cholesterol (mg/dL)
Men 51.4 (12.1) 48.7 (13.6) 50.2 (13.7) 47.3 (13.2)* 46.5 (12.3)** 46.3 (10.7)**
Women 62.8 (14.1) 55.2 (12.6)** 59.7 (13.5)** 53.0 (11.7)** 50.5 (12.5)** 52.8 (11.2)**
Triglycerides (mg/dL)1
Men 110.0 (1.7) 140.7 (1.7)** 136.9 (1.7)** 162.1 (1.9)** 156.5 (1.9)** 136.9 (1.7)**
Women 85.1 (1.6) 125.9 (1.6)** 110.1 (1.5)** 154.7 (1.4)** 155.4 (1.7)** 139.1 (1.8)**
Creatinine (mg/dL)1
Men 0.98 (1.18) 0.99 (1.21) 1.01 (1.21) 1.0 (1.17) 1.03 (1.25) 1.07 (1.31)**
Women 0.78 (1.18) 0.79 (1.20) 0.81 (1.21)* 0.87 (1.25)** 0.85 (1.20)** 0.86 (1.27)**
Alcohol intake (%)
Men $40.0 g/d 19.4 24.0 20.4 31.0 27.9 19.3
Women $20.0 g/d 15.6 23.7 11.9 14.8 14.9 8.4
Regular smoking (%)
Men 20.5 8.0** 8.8** 9.5 14.8 12.6*
Women 15.2 13.2 4.8** 7.4 6.4 7.4*
Physically active during leisure time (%)
Men 57.9 50.7** 45.6 50.0 52.5 34.8**
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(95% CI 1.44–4.26), i-IGT: OR 1.13 (95% CI 0.71–1.78), IFG/
IGT: OR 1.15 (95% CI 0.55–2.42), NDD: OR 0.94 (95% CI
0.48–1.81), known diabetes: OR 1.11 (95% CI 0.68–1.82).
In the analysis regarding the association between uric acid level
(continuous) and impaired glucose regulation groups combined
(reference group NGT) as the outcome, it could be shown, that in
women after multivariable adjustment uric acid levels were
significantly associated with impaired glucose regulation (the OR
per mg/dL increment of uric acid was 1.34; 95% CI 1.17–1.54); in
men, however, the association was not significant (OR per mg/dl
increment of uric acid: 1.11; 95% CI 0.99–1.24).
Discussion
Uric acid levels were significantly associated with different
categories of impaired glucose regulation independent of known
metabolic risk factors and lifestyle variables in men and women
from the general population. The associations were more
pronounced in women than in men. It could be shown that
prediabetic subjects and persons with newly diagnosed diabetes
had higher uric acid levels than normoglycemic subjects. In the
present investigation persons with known diabetes had also higher
Table 1. Cont.
NGT i-IFG i-IGT IFG/IGT NDD
Known
diabetes
Men n=971 n=75 n=147 n=42 n=61 n=135
Women n=1,164 n=38 n=168 n=27 n=47 n=95
Women 58.5 34.2** 53.0 59.3 40.4* 39.0**
NGT, normal glucose tolerance; NDD, newly detected diabetes; i-IFG, isolated impaired fasting glucose; i-IGT, isolated impaired glucose tolerance.
1geometric mean (SD);
*p,.05;
**p,.01 for comparisons with NGT.
doi:10.1371/journal.pone.0037180.t001
Table 2. Association of uric acid values with i-IFG, i-IGT, IFG/IGT, NDD, and known diabetes (comparisons with NGT), KORA F4
study.
i-IFG i-IGT IFG/IGT NDD Known diabetes
Total sample (n =113) (n =315) (n =69) (n=108) (n=230)
Men (n =75) (n =147) (n =42) (n=61) (n=135)
Women (n=38) (n =168) (n =27) (n=47) (n=95)
{Model 1: OR (95%-CI)
Total sample 1.66 (1.43–1.92) 1.26 (1.14–1.40) 1.57 (1.31–1.89) 1.57 (1.35–1.83) 1.55 (1.38–1.73)
Men 1.59 (1.33–1.90) 1.24 (1.08–1.43) 1.35 (1.06–1.71) 1.20 (0.98–1.47) 1.29 (1.11–1.50)
Women 1.77 (1.36–2.31) 1.31 (1.12–1.54) 1.99 (1.49–2.67) 2.24 (1.79–2.80) 2.07 (1.73–2.48)
{Model 2: OR (95%-CI)
Total sample 1.73 (1.47–2.03) 1.25 (1.12–1.40) 1.49 (1.22–1.83) 1.45 (1.23–1.71) 1.40 (1.24–1.59)
Men 1.67 (1.37–2.04) 2.21 (1.04–1.41) 1.26 (0.97–1.63) 1.09 (0.88–1.36) 1.19 (1.02–1.40)
Women 1.90 (1.41–2.55) 1.32 (1.12–1.57) 1.95 (1.40–2.72) 2.11 (1.63–2.72) 1.86 (1.52–2.28)
1Model 3: OR (95%-CI)
Total sample 1.61 (1.37–1.91) 1.20 (1.07–1.34) 1.33 (1.09–1.64) 1.30 (1.09–1.53) 1.30 (1.15–1.48)
Men 1.59 (1.29–1.96) 1.17 (1.00–1.37) 1.15 (0.88–1.50) 0.99 (0.79–1.24) 1.12 (0.95–1.32)
Women 1.71 (1.25–2.32) 1.25 (1.05–1.49) 1.69 (1.20–2.39) 1.84 (1.41–2.39) 1.69 (1.37–2.09)
||Model 4: OR (95%-CI)
Total sample 1.50 (1.26–1.77) 1.10 (0.98–1.24) 1.22 (0.98–1.50) 1.18 (1.00–1.40) 1.17 (1.03–1.34)
Men 1.49 (1.21–1.84) 1.09 (0.93–1.28) 1.06 (0.81–1.39) 0.91 (0.72–1.14) 1.04 (0.88–1.23)
Women 1.57 (1.15–2.14) 1.14 (0.95–1.36) 1.52 (1.07–2.16) 1.67 (1.28–2.17) 1.47 (1.18–1.82)
P-value for uric acid*sex interaction (Total sample) 0.8027 0.7449 0.0720 0.0007 0.0172
Odds ratio (OR) expressed per mg/dL increment in uric acid concentration; if the confidence intervals around the odds ratios overlap, then the odds ratios are not
significantly different
{Model 1: adjusted for age and sex (only total sample).
{Model 2: adjusted for age, sex, actual hypertension, regular smoking, physical activity, alcohol intake, and creatinine.
1Model 3: adjusted for age, sex, actual hypertension, regular smoking, physical activity, alcohol intake, creatinine, total cholesterol, and HDL cholesterol.
||Model 4: adjusted for age, sex, actual hypertension, regular smoking, physical activity, alcohol intake, creatinine, total cholesterol, HDL cholesterol, and BMI.
doi:10.1371/journal.pone.0037180.t002
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uric acid levels than non-diabetic persons, a finding which is
contrary to other studies [11–13,18].
Prior cohort studies have reported gender differences in the
relationship between uric acid levels and the development of
diabetes [17–20]. An earlier study of a different sample of the
MONICA/KORA study already demonstrated a clear association
between uric acid levels and incident diabetes that was present in
women and not in men [17]. In another study, Yamada et al.
reported that elevated serum uric acid predicted IFG and type 2
diabetes only in Japanese women but not in men undergoing
health checkups [20]. Chou et al found that serum uric acid levels
were associated with insulin resistance and plasma glucose levels
more strongly in women than in men [19].
Only a few, very early, cross-sectional studies have investigated
the association between uric acid levels and different glucose
tolerance groups in men and women from the general population
[11–13]. It was found that uric acid was significantly elevated in
people with IGT [11], and in those with fasting plasma glucose up
to 7.0–8.0 mmol/l in men and to 9.0 mmol/l in women
[12,21,22]. Among persons with NDD notably low uric acid
levels were observed [11–13,21], a finding which is in contrast
with the present results.
In the present study in multivariable adjusted multinomial
regression analysis we could show that among women high uric
acid levels were associated with each single category of glucose
intolerance (besides i-IGT). However, this was not the case in men,
in whom only the association between uric acid levels and i-IFG
persisted after multivariable adjustment. These findings under-
score a possible role of uric acid in the early pathogenesis of type 2
diabetes, particularly in women. It seems that hyperuricemia had a
high specificity for men and women with i-IFG, a state of impaired
glucose regulation, which differs from other prediabetic states [23].
Although both types of prediabetes that is i-IFG and/or i-IGT are
associated with an increased risk for developing type 2 diabetes
mellitus, they manifest distinct metabolic abnormalities. Impaired
fasting glucose is more strongly associated with insulin resistance
than impaired glucose tolerance and the aetiologies of i-IFG and i-
IGT seem to differ [23]. Thus, one possible explanation for the
found differences in the present work is that uric acid may play a
main role in the aetiology of insulin resistance. However, the
underlying pathophysiologic mechanisms for the strong association
between hyperuricaemia and i-IFG and the reasons for the gender
differences are not clear and should be subject of further
investigations. It has been shown, that there are strong sex-specific
effects in the genetic basis of uric acid production [24], possibly
suggesting a genetic basis for the sex differences even in glucose
metabolism.
Thus, although it remains unclear whether or not hyperurice-
mia is a consequence of insulin resistance or its precursor [25,26]
and the results of a very recent study do not support a causal role
for serum uric acid in the development of type 2 diabetes [27], the
simple measurement of uric acid might help to identify persons
with impaired glucose regulation, in particular persons with i-IFG.
An early identification of subjects suffering from a prediabetic state
would help to prevent or delay the development of diabetes and its
complications.
A number of mechanisms have been suggested by which uric
acid could affect changes in glucose metabolism. Elevated serum
uric acid was found to be associated with oxidative stress and
systemic inflammation both of which play crucial roles in the
development of diabetes mellitus [28]. Furthermore, uric acid
decreases endothelial nitric oxide production and thus induces
endothelial dysfunction and insulin resistance [29,30]. Finally, uric
acid is related to increased renal glomerular pressure and
increased renal sodium reabsorption, and these renal reactions
are greatly enhanced by high insulin concentrations [25]. The
combined effects of insulin resistance and high uric acid levels on
renal functions may contribute to increased glucose intolerance,
hypertension, and the development of diabetes.
The cross-sectional design of the study represents a limitation,
implicating that cause and effect relationships cannot be discerned.
Furthermore, although we adjusted for a variety of important
confounding variables, such as alcohol consumption, smoking, and
renal function, we cannot exclude that unknown risk factors may
have biased or confounded the present analysis. The strength of
the study is the large number of subjects randomly drawn from the
general population, and the availability of data on lifestyle and
multiple metabolic risk factors.
In conclusion, serum concentrations of uric acid were indepen-
dently associated with different states of impaired glucose
regulation in particular in women from the general population.
Further studies, in particular prospective studies are needed to
investigate the contribution of uric acid to the pathogenesis of
prediabetic states and finally to the manifestation of type 2
diabetes.
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